Back

The European Medicines Agency's list of critical medicines: policies and impact on cardiovascular drug availability

14 April 2026 (13:15 - 13:30)
Organised by: Logo
Congress Presentation Part of: Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type Antiarrhythmic Drug Treatment EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Ms Maria Luisa Ronconi

(Belgium)

3 More presentations in this session

Presentation thumbnail
Mapping the crisis: insights from the EHRA survey on anti-arrhythmic drug availability
Doctor P. Postema (Amsterdam, NL)
Video
Presentation thumbnail
Fostering innovation: advancing research and development of next-generation anti-arrhythmic drugs
Associate Professor C. Remme (Amsterdam, NL)
Video
Presentation thumbnail
Ensuring access to critical drugs: harnessing policy, technology, and advocacy
Professor L. Szumowski (Warsaw, PL)
Slides Video

Access the full session

Session thumbnail
Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type
Video

The Event

Event poster

EHRA 2026

14 April 2026 13:15 CET
You may be interested in
thumbnail
Congress Session
Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type
thumbnail
Congress Presentation
Ensuring access to critical drugs: harnessing policy, technology, and advocacy
thumbnail
Congress Presentation
Mapping the crisis: insights from the EHRA survey on anti-arrhythmic drug availability

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources